Staq Pharma, Inc.
Denver, CO, United States
This page shows every FDA and USDA recall linked to Staq Pharma, Inc.. Each entry includes the product involved, when the recall happened, and how serious it was. If a company has had multiple recalls over the years, you can see the full history here in one place — including whether any were Class I, which is the most serious type.
3
Total Recalls
2022
First Recall
2025
Most Recent
1
Class I (Most Serious)
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14...
Oct 22, 2025
· Drug
Class III
Ongoing
ROPivacaine HCl 0.2% PF in Sodium Chloride 1,000 mg/500 mL (2 mg per mL) Injection, 500 mL bags, Rx only, STAQ...
Dec 13, 2023
· Drug
Class II
Completed
HYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma,...
Feb 23, 2022
· Drug
Class I
Terminated